IMC Chicago’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486M Buy
1,006,100
+402,600
+67% +$107M 0.12% 128
2026
Q1
$66.1M Sell
603,500
-72,800
-11% -$10.4M 0.02% 408
2025
Q4
$113M Sell
676,300
-107,400
-14% -$18M 0.04% 271
2025
Q3
$153M Buy
783,700
+403,800
+106% +$66.4M 0.06% 190
2025
Q2
$34.4M Buy
379,900
+32,100
+9% +$2.54M 0.02% 499
2025
Q1
$20.8M Sell
347,800
-6,500
-2% -$601K 0.01% 565
2024
Q4
$46.9M Buy
354,300
+192,600
+119% +$18.1M 0.02% 363
2024
Q3
$8.47M Buy
161,700
+88,600
+121% +$4.16M ﹤0.01% 901
2024
Q2
$4.42M Buy
73,100
+33,800
+86% +$2.34M ﹤0.01% 1124
2024
Q1
$2.92M Buy
+39,300
New +$2.91M ﹤0.01% 1185

Other funds holding ALAB

IMC Chicago's ALAB Position: Q2 2026 in Review

IMC Chicago sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 176,073 shares — an estimated $46.7M sold.

IMC Chicago first reported a position in ALAB in Q4 2024 and held it in 6 quarters. The position peaked at $32.3M in Q4 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • IMC Chicago reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 176,073 Astera Labs shares in Q2 2026, an estimated $46.7M.
  • IMC Chicago first reported a position in Astera Labs in Q4 2024 and held it in 6 quarters.
  • IMC Chicago's Astera Labs position peaked at $32.3M in Q4 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.